Doncaster Pharma alerts MHRA over Braille embossing error on Hiprex 1 g tablets

Doncaster Pharma Limited has informed the Medicines and Healthcare products Regulatory Agency (MHRA) of an error concerning the Braille embossing on the outer packaging of specific parallel‑imported batches of Hiprex 1 g tablets (prescription‑only medicine). The notification highlights a packaging issue that may affect accessibility for visually impaired users. No further details on the scope of the affected batches were provided.